NCT02294227 - 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis | Biotech Hunter

Enrollment

341

Participants

Timeline

Start Date

May 29, 2015

Primary Completion Date

February 16, 2016

Study Completion Date

December 19, 2017

Conditions

Arthritis, Psoriatic

Interventions

BIOLOGICAL

Secukinumab

Secukinumab 150 mg (1 mL liquid formulation) in pre-filled syringes were supplied by Novartis. Each secukinumab 300 mg dose was given as two sc injections of secukinumab 150 mg.

OTHER

Placebo

Placebo to secukinumab was also available in 1.0 mL liquid formulation in prefilled syringe to match the active drug.

Trial Locations (64)

1070

Novartis Investigative Site, Brussels

1200

Novartis Investigative Site, Brussels

1431

Novartis Investigative Site, Sofia

2217

Novartis Investigative Site, Kogarah

3145

Novartis Investigative Site, Malvern East

4000

Novartis Investigative Site, Plovdiv

4558

Novartis Investigative Site, Maroochydore

5530

Novartis Investigative Site, Yvoir

7000

Novartis Investigative Site, Hobart

9300

Novartis Investigative Site, Aalst

12206

Novartis Investigative Site, Albany

16635

Novartis Investigative Site, Duncansville

20089

Novartis Investigative Site, Rozzano

20095

Novartis Investigative Site, Hamburg

22415

Novartis Investigative Site, Hamburg

29460

Novartis Investigative Site, Charleston

29601

Novartis Investigative Site, Greenville

31582

Novartis Investigative Site, Nienburg

34195

Novartis Investigative Site, Montpellier

34239

Novartis Investigative Site, Sarasota

34684

Novartis Investigative Site, Palm Harbor

37075

Novartis Investigative Site, Göttingen

37126

Novartis Investigative Site, Verona

39110

Novartis Investigative Site, Magdeburg

40138

Novartis Investigative Site, Bologna

44649

Novartis Investigative Site, Herne

48081

Novartis Investigative Site, Saint Clair Shores

60528

Novartis Investigative Site, Frankfurt am Main

61602

Novartis Investigative Site, Peoria

63117

Novartis Investigative Site, St Louis

68516

Novartis Investigative Site, Lincoln

71101

Novartis Investigative Site, Shreveport

72037

Novartis Investigative Site, Le Mans

73103

Novartis Investigative Site, Oklahoma City

75150

Novartis Investigative Site, Mesquite

80230

Novartis Investigative Site, Denver

85202

Novartis Investigative Site, Mesa

91054

Novartis Investigative Site, Erlangen

91786

Novartis Investigative Site, Upland

98104

Novartis Investigative Site, Seattle

98122

Novartis Investigative Site, Seattle

150003

Novartis Investigative Site, Yaroslavl

185019

Novartis Investigative Site, Petrozavodsk

190068

Novartis Investigative Site, Saint Petersburg

620028

Novartis Investigative Site, Yekaterinburg

620035

Novartis Investigative Site, Yekaterinburg

05401

Novartis Investigative Site, Burlington

V8V 3M9

Novartis Investigative Site, Victoria

R3A 1M1

Novartis Investigative Site, Winnipeg

H9R 3J1

Novartis Investigative Site, Pointe-Claire

G8Z 1Y2

Novartis Investigative Site, Trois-Rivières

792 01

Novartis Investigative Site, Bruntál

748 01

Novartis Investigative Site, Hlučín

128 50

Novartis Investigative Site, Prague

140 00

Novartis Investigative Site, Prague

686 01

Novartis Investigative Site, Uherské Hradiště

15-461

Novartis Investigative Site, Bialystok

62 069

Novartis Investigative Site, Dopiewo

82-300

Novartis Investigative Site, Elblag

90-265

Novartis Investigative Site, Lodz

60-218

Novartis Investigative Site, Poznan

61 113

Novartis Investigative Site, Poznan

SE-17176

Novartis Investigative Site, Stockholm

E11 1NR

Novartis Investigative Site, Leytonstone